BioNexus Gene Lab Corp
NASDAQ:BGLC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indian Bank
NSE:INDIANB
|
IN |
|
Japan Steel Works Ltd
OTC:JPSWY
|
JP |
BioNexus Gene Lab Corp
Total Current Liabilities
BioNexus Gene Lab Corp
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BioNexus Gene Lab Corp
NASDAQ:BGLC
|
Total Current Liabilities
$678k
|
CAGR 3-Years
-20%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
|
BioNexus Gene Lab Corp
Glance View
BioNexus Gene Lab Corp. is a molecular diagnostics company, which focuses on the application of functional genomics to enable diagnosis and personalized health management. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan and currently employs 8 full-time employees. The company went IPO on 2020-03-11. The firm is focused on the application of functional genomics to enable early diagnosis and personalized health management. The firm's wholly owned subsidiaries include Bionexus Gene Lab Sdn. Bhd. (Bionexus Malaysia) and Chemrex Sdn. Bhd. (Chemrex). BioNexus Malaysia owns algorithm software, technology and know-how related to the detection of common diseases through blood analysis which it uses in its business. Its non-invasive blood screening tests analyze changes in ribonucleic acid (RNA) to detect the risk potentiality of approximately 11 different diseases. These diseases include cancers, bowel diseases and osteoarthritis. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asia Pacific region.
See Also
What is BioNexus Gene Lab Corp's Total Current Liabilities?
Total Current Liabilities
678k
USD
Based on the financial report for Sep 30, 2025, BioNexus Gene Lab Corp's Total Current Liabilities amounts to 678k USD.
What is BioNexus Gene Lab Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
76%
Over the last year, the Total Current Liabilities growth was -52%. The average annual Total Current Liabilities growth rates for BioNexus Gene Lab Corp have been -20% over the past three years , 76% over the past five years .
